Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valproic Acid Metabolic Effects in Bipolar Disorder
NCT04486092Unknown
- Sponsor
- National Cheng Kung University Hospital
- Start
- Feb 2015
- Primary completion
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of valproic acid in bipolar disorder (BD), sponsored by National Cheng Kung University Hospital. Primary endpoint: Gut microbiota composition at 12 weeks. Status: unknown.
02
Drugs
valproic acid
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT04486092.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04486092.